SALIX PHARMACEUTICALS LTD DEL
SLXP
SLXP was delisted on the 31st of March, 2015.
1 hedge funds and large institutions have $72K invested in SALIX PHARMACEUTICALS LTD DEL in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
1,100% more capital invested
Capital invested by funds: $6K → $72K (+$66K)
0% more funds holding
Funds holding: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAM
Mizuho Asset Management
Tokyo,
Japan
|
+$72K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCS
Crosspoint Capital Strategies
Orinda,
California
|
-$6K |
SLXP Hedge Fund Activity: Q1 2016 in Review
1 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in SALIX PHARMACEUTICALS LTD DEL (SLXP) for Q1 2016, worth a combined $72K — up 1,100% from $6K a quarter earlier.
Fund positioning in SLXP was balanced in Q1 2016: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was Mizuho Asset Management, opening a new position worth an estimated $72K. The largest seller was Crosspoint Capital Strategies, exiting entirely with an estimated $6K sold.
- 1 institutional investor held SALIX PHARMACEUTICALS LTD DEL (SLXP) as of Q1 2016, unchanged from Q4 2015.
- Funds reported $72K of SALIX PHARMACEUTICALS LTD DEL stock for Q1 2016, up 1,100% quarter-over-quarter.
- 1 fund opened new SALIX PHARMACEUTICALS LTD DEL positions in Q1 2016 and 1 closed out, a net change of 0 holders.
- The largest SALIX PHARMACEUTICALS LTD DEL buyer in Q1 2016 was Mizuho Asset Management, an estimated $72K added.
- The largest SALIX PHARMACEUTICALS LTD DEL seller in Q1 2016 was Crosspoint Capital Strategies, an estimated $6K sold.
Based on aggregated 13F filings for Q1 2016.